Monoallelic <i>CRMP1</i> gene variants cause neurodevelopmental disorder.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36511780.
- Also identified by DOI 10.7554/eLife.80793 and PMC identifier 9803352.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Collapsin response mediator proteins (CRMPs) are key for brain development and function. Here, we link CRMP1 to a neurodevelopmental disorder. We report heterozygous de novo variants in the <i>CRMP1</i> gene in three unrelated individuals with muscular hypotonia, intellectual disability, and/or autism spectrum disorder. Based on in silico analysis these variants are predicted to affect the CRMP1 structure. We further analyzed the effect of the variants on the protein structure/levels and cellular processes. We showed that the human <i>CRMP1</i> variants impact the oligomerization of CRMP1 proteins. Moreover, overexpression of the <i>CRMP1</i> variants affect neurite outgrowth of murine cortical neurons. While altered CRMP1 levels have been reported in psychiatric diseases, genetic variants in <i>CRMP1</i> gene have never been linked to human disease. We report for the first-time variants in the <i>CRMP1</i> gene and emphasize its key role in brain development and function by linking directly to a human neurodevelopmental disease.
Medical subject headings
- Autism Spectrum Disorder
- Intellectual Disability
- Neurodevelopmental Disorders